Latest

brain cancer vaccine

Brain Cancer Featured Neurology Neuroscience

·May 9, 2025·3 min read

Glioblastoma Vaccine Trial Moves Forward

The phase 2B SURVIVE trial testing SurVaxM, a cancer vaccine for glioblastoma, will continue as planned following an interim analysis showing sufficient promise to proceed. SurVaxM, combined with standard treatments like surgery, radiation, and chemotherapy, aims to extend survival and improve quality of life for patients with this aggressive brain cancer.

Brain Cancer Featured Neurology Neuroscience

·November 21, 2022·6 min read

Phase 3 Clinical Trial: Brain Cancer Vaccine Shows Promising Results

Results of a phase three clinical trial of a novel brain cancer vaccine, DCVax-L, that uses a patient's stem cells to target cancer cells extend survival by many months to years for glioblastoma patients.

MRI scans from a person with glioblastoma brain cancer

Brain Cancer Featured Neurology Open Neuroscience Articles

·May 31, 2018·5 min read

Brain Cancer Vaccine Effective in Some Patients

Researchers report a clinical trial of a personalized vaccine that targets glioblastoma brain cancer has successfully improved survival rates for patients.